![]() |
|||||||
|
Letter from the PresidentDear Colleagues,
FOCIS 2008, the premiere conference in translational immunology, is fast approaching, and we invite you to attend and participate. The FOCIS 2008 Organizing Committee, led by Jacques Banchereau, has selected topics and speakers from a comprehensive array of disease areas that address underlying immune pathogenesis, novel therapies, and shared insights. This year’s program features topics such as Tolerance & Autoimmunity: New Mechanisms and Therapeutic Targets; Innovations in Genetic Approaches; Movers and Shakers: Cellular Migration and Immunomodulation; and Communicating Danger: Inflammatory Mediators. As our field rapidly advances in clinical trials and the introduction of new and specific immunotherapies, the opportunity to share our knowledge and speed our progress has never been greater. A complete listing of the FOCIS 2008 science and speakers are available in the Preliminary Program. In addition to the scientific program, FOCIS 2008 also hosts FOCIS Member Societies’ Satellite Symposia and FOCIS Educational Courses. Satellite symposia provide the opportunity for in-depth coverage of more focused topics which are of particular interest to specific member societies, and serve as a prelude to the excitement of the FOCIS 2008 meeting itself. The listing of June 5 satellites can be found at http://www.focisnet.org/meetings/am08/Satellite-Symposia.php. The FOCIS Education Committee, led by Andy Lichtman, and Interventional Immunology Course Director, William St. Clair, have developed a new education program that will debut also on June 5. This course on interventional immunology is designed primarily for practitioners to assist them in identifying cross-disciplinary implications of current therapies. This course in combination with the Basic Immunology in Medicine: Update 2008 Course held June 4 offers a comprehensive education experience from bedside to bench and back again. The FOCIS 2008 programs are a major element fueling the FOCIS mission to improve human health through immunology. We look forward to your participation and energy at FOCIS 2008 to further this goal. See you in Boston! Best regards,
Gerald T. Nepom, MD, PhD • • • • •
Register for FOCIS 2008 NOW for Discounted Rates
|
||||||
|
• • • • •
FOCIS 2008 Member Society Satellite Symposia: Thursday, June 5, 2008To attend FOCIS 2008 Satellite Symposia, delegates MUST indicate this option on the FOCIS 2008 registration form and pay an additional fee, ranging from $45 for a half day ticket to $75 for a full day ticket. To learn more about Satellite Symposia, visit http://www.focisnet.org/meetings/am08/Satellite-Symposia.php. Full Day (8:30 am-5:30 pm) Member Society Satellite Symposia include:
Half Day Morning Only (8:30 am-5:30 pm) Member Society Satellite Symposia include:
Half Day Afternoon Only (12:30 pm-5:30 pm) Member Society Satellite Symposia include:
• • • • •
|
|||||||
![]() |
Basic Immunology in Medicine: Update 2008
|

Basic Immunology in Medicine: Update 2008 provides a sophisticated review of selected basic principles, and an update on new advances, especially those that are most relevant to human disease. Staying abreast of these advances is essential for practitioners of medicine and for researchers in academia and industry.
FOCIS is proud to announce the launch of Interventional Immunology. This one-day course recognizes the need for and provides education on the many new therapies that are currently available or in development which are based on targets unfamiliar to many practicing physicians.
![]() |
Interventional Immunology
|
The goal is to help understand the rationale and mechanism underlying the major pharmacologic approaches for interventional immunology in current practice and review the track record of the different therapeutic approaches in different specialties.
The Federation of Clinical Immunology Societies (FOCIS) connects multiple disease specific, genetic consortia under the FOCIS Network of Consortia in an effort to uncover the genetic basis of autoimmunity. The Network recently completed genome wide association scans revealing novel candidate genes that may provide important insights into disease pathogenesis and therapeutic targets.
The results were presented for the first time on June 11, 2007 at the Federation’s Annual Meeting (FOCIS 2007) in San Diego. The NOC unites again on June 9 at FOCIS 2008 in Boston to present reports from additional consortia who have completed their scans and have new data to share.
“Scientists that once worked in disease-specific silos are uniting to create a catalogue of common genetic variations that will enable scientists to unravel underlying causes of autoimmune diseases. New data across diseases is showing great commonality, identifying potential targets that work across autoimmune diseases.”
-Stephen Rich, PhD, University of Virginia
Network of Consortia Chair
March 15 - ALL abstract authors must have completed a disclosure form or the abstract will be withdrawn
April 14 - Headquarters hotel meeting registration discount deadline
May 1 - Advance meeting registration deadline
June 5-9 - FOCIS 2008 at the Boston Marriott Copley Place
The Advanced Course in Basic & Clinical Immunology presented to a sold-out crowd for the third year in a row at the end of February in Scottsdale, Arizona. This course, which has had a waiting list of over 45 people each year since its inception covers topics such as Leukocyte Migration, Cytokines and T Cell Subsets, and New and Emerging Immune Therapies.

Special thanks to FOCIS industry partners:
Mark your calendars for February 18-22, 2009!
Click here to view more photos from the course
The growing enthusiasm emanating from meetings heralding the discoveries of cytokines and growth factors during the 1980s laid the foundation for the formation of the International Cytokine Society, officially established in 1993 under the auspicious of Dr. Sherwood Reichard, current Executive Director (www.weizmann.ac.il/cytokine/). Joost J. Oppenheim was elected the first President of the ICS. Carl Ware is current President of the ICS.
With well over several hundred distinct cytokines, receptors and signaling components an urgent need has emerged to integrate basic and clinical knowledge. The main goal of the ICS is to facilitate the integration of knowledge among scientists and clinicians, and provide a stimulating forum for students, fellows and new investigators to learn, network and establish their careers.
Members of the ICS have contributed extensively to the development of drugs targeting cytokines that have proven highly successful in the clinic. For instance, the research of Jan Vilcek and Marc Feldmann, both past presidents of ICS, was instrumental in developing and advancing antibody-based TNF inhibitors, now widely used in treating several autoimmune diseases, including rheumatoid arthritis, Crohn’s disease, and psoriasis.
Drs. John Sims and Carl Ware will host the ICS sponsored satellite session at FOCIS, "Emerging Cytokine-Based Therapeutics", 1:30 to 5:30pm on Thursday, June 5. The goal of the session is to highlight new therapeutics that modulate the activity of cytokines and are in clinical trials with demonstrated promise, but not talked about extensively at other meetings. A significant discussion of the underlying biology and pathophysiological hypothesis which led to the trial(s) will be presented. The agenda for the session includes new therapies directed at TNF superfamily in cancer and autoimmune diseases, IL-1 inhibition in type II diabetes, chemokine inhibition in atherosclerosis, and IL2 blockade in multiple sclerosis. Register for the ICS Satellite at www.focisnet.org.
The Annual Meeting of the ICS, now in its 14th year, provides a consistent forum for communication and interaction between scientists aimed at the multidisciplinary integration of basic and clinical knowledge of cytokines. The ICS Annual meeting is held jointly with the International Society for Interferon and Cytokine Research. The Fairmont Queen Elizabeth Hotel in Montréal will host “Cytokines 2008”, October 12-16, 2008. Dr. John Hiscott will chair the meeting. Generous travel awards are available for young scientists to attend the annual meeting. www.cytokines2008.org.
Wednesday, June 4, 2008
2:00 pm – 6:00 pm – Dinner to follow
Boston Marriott Copley Place
Boston, Massachusetts, USA
Please note, the FCE Trainee Satellite Symposium follows the FCE Directors meeting on Thursday, June 5. All FCE Directors are encouraged to attend to support and interact with trainees from the 50 FCEs across the globe.
Please be reminded to complete and submit FCE Year End Reports by March 31, 2008.
Center Director: Robert Kimberly
FOCIS: What is the coolest way that you facilitate interdisciplinary research?
Kimberly: Building on the example of the B Cell Outreach Program, the UAB FCE has developed a campus-wide program focusing on “Opportunities in Human Immunology.” Meeting every 8-10 weeks, each thematically coordinated session in the Opportunities series brings together on-campus investigators to give a brief précis of their work. After a research seminar by a distinguished visiting scientist, the presentations are designed to identify and highlight newly appreciated research opportunities in human immunology. The visiting scientist serves as co-moderator and commentator as they bring additional perspectives from their own host institution. Themes for the Opportunities series have included B cells (the inaugural topic), T cells, innate immunity, and immunogenetics.
FOCIS: Why do you dig immunology?
Kimberly: Immunology is particularly well suited to a campus-wide program because it integrates classical studies of adaptive immunity with inflammation, vascular biology, genetics and host defense. Immunology touches every organ system and is an ideal springboard for integrative, translational research.
FOCIS: What’s your vision for the future of immunology?
Kimberly: The importance of immunology, both fundamental and clinical, will continue to grow as the impact of immunologic and inflammatory mechanisms in organismal biology increases. Immunology presents enormous opportunities in complex genetics and systems biology.
Job postings should be 250 words or less and will remain on the website for 90 days. To post your opportunities please contact Sarah Krause.
October 2007 – September 2008
Oxford University, United Kingdom
March 25-26, 2008
Washington, DC
March 27 - April 1, 2008
Banff, Alberta, Canada
April 2-6, 2008
Boston, Massachusetts, USA
June 4, 2008
Boston, Massachusetts, USA
June 5, 2008
Boston, Massachusetts, USA
June 5-9, 2008
Boston, Massachusetts, USA
June 26-27, 2008
Nantes, France
July 23 - 26, 2008 (Welcome Reception the evening of July 22)
Aspen, Colorado, USA
August 10-14, 2008
Sydney, Australia
August 22-27, 2010
Kobe, Japan
September 13-20, 2008
Rio de Janeiro, Brazil
August 30 - September 2, 2008
International meeting of the Americas, European and Latin American Committees for Treatment and Research of Multiple Sclerosis
September 17 - 20, 2008
Montreal, Quebec, Canada
October 4 -7, 2008
Antalya, Turkey
American Academy of Allergy, Asthma and Immunology
• American College of Rheumatology
American Society for Blood and Marrow Transplantation
• American Society for Histocompatibility and Immunogenetics
American Society of Nephrology
• American Society of Transplantation
• American Uveitis Society
Americas Committee for Treatment and Research in Multiple Sclerosis
• Association of Medical Laboratory Immunologists
Australasian Society of Clinical Immunology and Allergy
• Center for International Blood and Marrow Transplant Research
Clinical Immunology Chapter of the Sociedad Mexicana de Immunología
• Clinical Immunology Society
Commonwealth of Independent States Society of Allergology and Clinical Immunology
Croatian Society of Allergology and Clinical Immunology
• Crohn’s and Colitis Foundation of America
German Society of Immunology
• Immunology of Diabetes Society
• International Complement Society
International Cytokine Society
International Society for Interferon and Cytokine Research
International Society for NeuroImmunoModulation
•International Society of Neuroimmunology
International Society for Biological Therapy of Cancer
•Israel Association of Allergy and Clinical Immunology
Italian Society of Allergology and Clinical Immunology
Lithuanian Society of Pulmonology and Allergy
Pan American Group for Immunodefiency
•Section of Clinical Immunology and Allergy of the Royal Society of Medicine
Section for Clinical Immunology of the Swedish Society of Medicine
• Society for Investigative Dermatology
Society for Mucosal Immunology
• The Transplantation Society
• Ukrainian Society of Immunology and Allergy
Uveitis Association of Mexico
• World Allergy Organization